These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31627471)

  • 21. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling drug effects through improved oral formulations. The pharmacokinetics of the prazosin gastrointestinal therapeutic system.
    DiPiro JT
    Am J Med; 1989 Aug; 87(2A):31S-35S. PubMed ID: 2764016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled delivery of biotechnological products.
    Conti S; Polonelli L; Frazzi R; Artusi M; Bettini R; Cocconi D; Colombo P
    Curr Pharm Biotechnol; 2000 Dec; 1(4):313-23. PubMed ID: 11467329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel oral drug formulations. Their potential in modulating adverse effects.
    Florence AT; Jani PU
    Drug Saf; 1994 Mar; 10(3):233-66. PubMed ID: 8043223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modulation of in vivo fate of drugs: fundamental biopharmaceutical and pharmacokinetic aspects].
    Devissaguet JP
    Ann Pharm Fr; 2001 Jul; 59(4):219-26. PubMed ID: 11468575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape-A Summary of This Indispensable Special Issue.
    Davies NM; Wasan KM
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29337865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of drug delivery system based on a new administration route for targeting to the specific region in the liver].
    Nishida K
    Yakugaku Zasshi; 2003 Aug; 123(8):681-9. PubMed ID: 12931664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery Technologies for Orally Inhaled Products: an Update.
    Moon C; Smyth HDC; Watts AB; Williams RO
    AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug delivery systems for programmed and on-demand release.
    Davoodi P; Lee LY; Xu Q; Sunil V; Sun Y; Soh S; Wang CH
    Adv Drug Deliv Rev; 2018 Jul; 132():104-138. PubMed ID: 30415656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic aspects of biotechnology products.
    Tang L; Persky AM; Hochhaus G; Meibohm B
    J Pharm Sci; 2004 Sep; 93(9):2184-204. PubMed ID: 15295780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future of the transdermal drug delivery market--have we barely touched the surface?
    Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
    Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery.
    Madani F; Hsein H; Busignies V; Tchoreloff P
    Pharm Dev Technol; 2020 Feb; 25(2):133-148. PubMed ID: 31690146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery.
    Feitosa RC; Geraldes DC; Beraldo-de-Araújo VL; Costa JSR; Oliveira-Nascimento L
    Front Pharmacol; 2019; 10():1057. PubMed ID: 31607914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palatal mucosa as a route for systemic drug delivery: A review.
    Shakya P; Madhav NV; Shakya AK; Singh K
    J Control Release; 2011 Apr; 151(1):2-9. PubMed ID: 21059376
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.